CellWell record HH-137993
Mechanisms of Butyrate in Diabetes Through the Metabolism-Immunity Axis and Targeted Therapeutic Strategies
Hong-Wei Yu; Jian-Long Zhang; Fang-Jie Liu; Ying Liu; Wan-Neng Yan; Ze Yu
2026
In plain language
This review summarizes evidence that butyrate, a gut-microbiota-derived short-chain fatty acid, regulates glucose metabolism and immune function, positioning it as a potential therapeutic target in diabetes.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-137993
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.